ARK Investment Management’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,941,556
Closed -$23.9M 359
2021
Q4
$23.9M Sell
2,941,556
-841,207
-22% -$8.27M 0.07% 127
2021
Q3
$47.7M Sell
3,782,763
-876,255
-19% -$12.1M 0.11% 118
2021
Q2
$72.1M Sell
4,659,018
-458,508
-9% -$7.71M 0.13% 104
2021
Q1
$103M Sell
5,117,526
-1,561,551
-23% -$38.6M 0.21% 94
2020
Q4
$181M Buy
6,679,077
+2,543,994
+62% +$57.1M 0.48% 54
2020
Q3
$76.5M Buy
4,135,083
+1,355,756
+49% +$24.1M 0.45% 47
2020
Q2
$49.5M Buy
2,779,327
+1,231,281
+80% +$18.7M 0.53% 36
2020
Q1
$14.2M Buy
1,548,046
+206,045
+15% +$3.07M 0.36% 48
2019
Q4
$23M Buy
1,342,001
+102,138
+8% +$1.36M 0.58% 37
2019
Q3
$12.9M Buy
1,239,863
+136,677
+12% +$1.84M 0.28% 54
2019
Q2
$17.2M Buy
1,103,186
+169,110
+18% +$3.02M 0.43% 43
2019
Q1
$17.1M Buy
934,076
+219,740
+31% +$3.89M 0.49% 40
2018
Q4
$11.9M Buy
714,336
+320,294
+81% +$7.43M 0.48% 39
2018
Q3
$11.1M Buy
394,042
+149,779
+61% +$4.3M 0.34% 56
2018
Q2
$6.91M Buy
244,263
+156,666
+179% +$4.66M 0.25% 60
2018
Q1
$2.76M Buy
87,597
+43,215
+97% +$1.37M 0.14% 73
2017
Q4
$1.29M Buy
44,382
+28,048
+172% +$764K 0.1% 85
2017
Q3
$465K Buy
16,334
+12,296
+305% +$318K 0.06% 113
2017
Q2
$104K Buy
4,038
+1,784
+79% +$42.6K 0.02% 100
2017
Q1
$54K Buy
+2,254
New +$47.4K 0.02% 95

Other funds holding CLLS

ARK Investment Management's CLLS Position: Q1 2022 in Review

ARK Investment Management sold out of Cellectis (CLLS) in Q1 2022, closing a stake of 2,941,556 shares — an estimated $23.9M sold.

ARK Investment Management first reported a position in CLLS in Q1 2017 and held it in 20 quarters. The position peaked at $181M in Q4 2020. 51 funds tracked by Wall St. Rank hold CLLS as of Q1 2022.

  • ARK Investment Management reported no remaining Cellectis position as of Q1 2022 after selling out during the quarter.
  • ARK Investment Management sold 2,941,556 Cellectis shares in Q1 2022, an estimated $23.9M.
  • ARK Investment Management first reported a position in Cellectis in Q1 2017 and held it in 20 quarters.
  • ARK Investment Management's Cellectis position peaked at $181M in Q4 2020.
  • 51 funds tracked by Wall St. Rank held Cellectis as of Q1 2022.

Based on ARK Investment Management's 13F filing for Q1 2022, filed 19 Apr 2022.